Ciaran P Kelly1, Xinhua Chen1, David Williams2, Hua Xu1, Christine A Cuddemi1, Kaitlyn Daugherty1, Caitlin Barrett1, Mark Miller3, Agnès Foussadier3, Aude Lantz3, Alice Banz3, Nira R Pollock4,5. 1. Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Massachusetts. 2. Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Massachusetts. 3. bioMerieux, Marcy L'Etoile, France. 4. Division of Infectious Disease, Department of Medicine, Beth Israel Deaconess Medical Center. 5. Department of Laboratory Medicine, Boston Children's Hospital, Massachusetts.
Abstract
BACKGROUND: Recent data indicate that Clostridioides difficile toxin concentrations in stool do not differentiate between C. difficile infection (CDI) and asymptomatic carriage. Thus, we lack a method to distinguish a symptomatic patient with CDI from a colonized patient with diarrhea from another cause. To address this, we evaluated markers of innate and adaptive immunity in adult inpatients with CDI (diagnosed per US guidelines), asymptomatic carriage, or non-CDI diarrhea. METHODS: CDI-NAAT patients had clinically significant diarrhea and positive nucleic acid amplification testing (NAAT) and received CDI treatment. Carrier-NAAT patients had positive stool NAAT but no diarrhea. NAAT-negative patients (with and without diarrhea) were also enrolled. A panel of cytokines and anti-toxin A and B immunoglobulin (Ig) were measured in serum; calprotectin and anti-toxin B Ig A/G were measured in stool. NAAT-positive stool samples were tested by an ultrasensitive toxin assay (clinical cutoff, 20 pg/mL). RESULTS: Median values for interleukin (IL)-4, IL-6, IL-8, IL-10, IL-15, granulocyte colony-stimulating factor (GCSF), MCP-1, tumor necrosis factor α (TNF-α), and IgG anti-toxin A in blood and IgA/G anti-toxin B in stool were significantly higher in CDI patients compared with all other groups (P < .05). Concentration distributions for IL-6, GCSF, TNF-α, and IgG anti-toxin A in blood, as well as IgA and IgG anti-toxin B in stool, separated CDI patients from all other groups. CONCLUSIONS: Specific markers of innate and adaptive immunity distinguish CDI from all other groups, suggesting potential clinical utility for identifying which NAAT- and toxin-positive patients with diarrhea truly have CDI.
BACKGROUND: Recent data indicate that Clostridioides difficile toxin concentrations in stool do not differentiate between C. difficileinfection (CDI) and asymptomatic carriage. Thus, we lack a method to distinguish a symptomatic patient with CDI from a colonized patient with diarrhea from another cause. To address this, we evaluated markers of innate and adaptive immunity in adult inpatients with CDI (diagnosed per US guidelines), asymptomatic carriage, or non-CDIdiarrhea. METHODS:CDI-NAATpatients had clinically significant diarrhea and positive nucleic acid amplification testing (NAAT) and received CDI treatment. Carrier-NAATpatients had positive stool NAAT but no diarrhea. NAAT-negative patients (with and without diarrhea) were also enrolled. A panel of cytokines and anti-toxin A and B immunoglobulin (Ig) were measured in serum; calprotectin and anti-toxin B Ig A/G were measured in stool. NAAT-positive stool samples were tested by an ultrasensitive toxin assay (clinical cutoff, 20 pg/mL). RESULTS: Median values for interleukin (IL)-4, IL-6, IL-8, IL-10, IL-15, granulocyte colony-stimulating factor (GCSF), MCP-1, tumor necrosis factor α (TNF-α), and IgG anti-toxin A in blood and IgA/G anti-toxin B in stool were significantly higher in CDIpatients compared with all other groups (P < .05). Concentration distributions for IL-6, GCSF, TNF-α, and IgG anti-toxin A in blood, as well as IgA and IgG anti-toxin B in stool, separated CDIpatients from all other groups. CONCLUSIONS: Specific markers of innate and adaptive immunity distinguish CDI from all other groups, suggesting potential clinical utility for identifying which NAAT- and toxin-positive patients with diarrhea truly have CDI.
Authors: Hua Yu; Kevin Chen; Ying Sun; Mihaela Carter; Kevin W Garey; Tor C Savidge; Sridevi Devaraj; Mary Elizabeth Tessier; Erik C von Rosenvinge; Ciaran P Kelly; Marcela F Pasetti; Hanping Feng Journal: Clin Vaccine Immunol Date: 2017-08-04
Authors: Nira R Pollock; Alice Banz; Xinhua Chen; David Williams; Hua Xu; Christine A Cuddemi; Alice X Cui; Matthew Perrotta; Eaman Alhassan; Brigitte Riou; Aude Lantz; Mark A Miller; Ciaran P Kelly Journal: Clin Infect Dis Date: 2019-01-01 Impact factor: 9.079
Authors: Linan Song; Mingwei Zhao; David C Duffy; Joshua Hansen; Kelsey Shields; Manida Wungjiranirun; Xinhua Chen; Hua Xu; Daniel A Leffler; Susan P Sambol; Dale N Gerding; Ciarán P Kelly; Nira R Pollock Journal: J Clin Microbiol Date: 2015-07-22 Impact factor: 5.948
Authors: Suchitra K Hourigan; Sankar R Chirumamilla; Tracy Ross; Jonathan E Golub; Shervin Rabizadeh; Shehzad A Saeed; Charles O Elson; Ciaran P Kelly; Karen C Carroll; Maria Oliva-Hemker; Cynthia Sears Journal: Inflamm Bowel Dis Date: 2013-12 Impact factor: 5.325
Authors: Carolyn D Alonso; Ciarán P Kelly; Kevin W Garey; Anne J Gonzales-Luna; David Williams; Kaitlyn Daugherty; Christine Cuddemi; Javier Villafuerte-Gálvez; Nicole C White; Xinhua Chen; Hua Xu; Rebecca Sprague; Caitlin Barrett; Mark Miller; Agnès Foussadier; Aude Lantz; Alice Banz; Nira R Pollock Journal: Clin Infect Dis Date: 2022-07-06 Impact factor: 20.999
Authors: Gregory R Madden; William A Petri; Deiziane V S Costa; Cirle A Warren; Jennie Z Ma; Costi D Sifri Journal: Antimicrob Agents Chemother Date: 2022-06-21 Impact factor: 5.938
Authors: Shanlin Ke; Nira R Pollock; Xu-Wen Wang; Xinhua Chen; Kaitlyn Daugherty; Qianyun Lin; Hua Xu; Kevin W Garey; Anne J Gonzales-Luna; Ciarán P Kelly; Yang-Yu Liu Journal: Gut Microbes Date: 2021 Jan-Dec
Authors: Jacob M Parnell; Irtiqa Fazili; Sarah C Bloch; D Borden Lacy; Valeria A Garcia-Lopez; Rachel Bernard; Eric P Skaar; Kathryn M Edwards; Maribeth R Nicholson Journal: J Pediatr Gastroenterol Nutr Date: 2021-03-01 Impact factor: 3.288
Authors: Carolyn D Alonso; Konstantinos Papamichael; Rebecca Sprague; Caitlin Barrett; Anne J Gonzales-Luna; Kaitlyn Daugherty; Kevin W Garey; Javier Villafuerte-Gálvez; Hua Xu; Qianyun Lin; Lamei Wang; Xinhua Chen; Nira R Pollock; Ciarán P Kelly Journal: Open Forum Infect Dis Date: 2021-06-01 Impact factor: 3.835